Q&A: Pharmacists Play Key Role in Retinal Therapy Support | Asembia 2025
Drug Topics
MAY 5, 2025
Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth discusses how pharmacists can reduce patient burden.
Drug Topics
MAY 5, 2025
Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth discusses how pharmacists can reduce patient burden.
PhRMA
MAY 5, 2025
PBM’s trade association, PCMA, recently launched a campaign to mask growing concerns over their role in the pharmaceutical supply chain and the rising cost of medicine for patients. The campaign is in response to elected officials nationwide joining the congressional momentum in calling for PBM reform. It’s time to rein in middlemen, like PBMs, who use medicines as a profit center and drive up the costs for patients, employers, and taxpayers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MAY 5, 2025
The two obesity leaders are pulling on all levers to stay on top of the market.
STAT
MAY 6, 2025
Five years ago, U.S. pharmaceutical companies didn’t license any new drugs from China. By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. Why are U.S. drugmakers sending their business to China? As in many other industries, it’s so much cheaper to synthesize new compounds inside Chinese biotechnology firms once a novel biological target has been discovered in American laboratories.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 9, 2025
The new at-home test aims to increase comfort and screening timeliness through a more accessible method.
Pharmafile
MAY 6, 2025
Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 5, 2025
The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).
PharmaVoice
MAY 6, 2025
Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem. But they’re still poised for change.
STAT
MAY 5, 2025
MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts. The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.
The Guardian - Pharmaceutical Industry
MAY 9, 2025
Providing semaglutide for all those eligible may bring productivity gains as people are able to work more Giving weight loss jabs to everyone eligible for them could boost the UK economy by 4.5bn, according to research. Worldwide, about 3.8 billion people over 25 and just under 750 million children and young people are forecast to be overweight or obese by 2050.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
MAY 6, 2025
Zinc is an essential nutrient for many bodily processes, such as immune function and wound healing. Your body doesnt naturally produce it, so you must consume it in the foods you eat or take a supplement to avoid a zinc deficiency. Luckily, many foods you probably already eat are chock-full of zinc, including seafood, red meat, poultry, whole grains, and legumes.
Drug Topics
MAY 6, 2025
The use of electronic prescribing can also bridge the gap in clinical history, which can help pharmacists be aware of adverse drug reactions and medication interactions.
Pharmaceutical Technology
MAY 6, 2025
The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.
PharmaVoice
MAY 5, 2025
While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MAY 6, 2025
WASHINGTON — Vinay Prasad, an academic and fierce critic of the medical mainstream, will be the next director of the Food and Drug Administration center that oversees the regulation of vaccines, gene therapies, and the blood supply. Prasad, previously an epidemiology professor at the University of California, San Francisco, has sharply criticized the FDA in the past, including the Center for Biologics Evaluation and Research, the unit he will now lead.
Pharmacy Times
MAY 6, 2025
Abigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.
Fierce Healthcare
MAY 9, 2025
Loss of services and support systems will result in the rollback of advancements made around human and civil rights for people with intellectual and developmental disabilities.
Drug Topics
MAY 9, 2025
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how its assisting with compliance.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PhRMA
MAY 1, 2025
Patients in the U.S. will soon be left with fewer new, affordable and convenient treatments, if Congress fails to fix a harmful provision in the Inflation Reduction Act (IRA) referred to as the “pill penalty.
European Pharmaceutical Review
MAY 5, 2025
New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.
STAT
MAY 9, 2025
WASHINGTON — U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company. Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can detect the HPV virus that causes cervical cancer.
Pharmacy Times
MAY 9, 2025
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
pharmaphorum
MAY 6, 2025
Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients
Drug Topics
MAY 12, 2025
Investigators find that unhealthy eating and inadequate or excessive sleeping duration could contribute to developing diabetic nephropathy.
PhRMA
MAY 1, 2025
The 340B hospital markup program continues to skyrocket every year. Yet there is little to no evidence that this immense growth is benefiting the uninsured and low-income patients that the program was designed to serve. If the money isn’t going to help patients, where is it going?
Pharmafile
MAY 9, 2025
Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study of GAL-101, a novel therapy aimed to treat serious neurodegenerative eye and brain conditions. The SAD study showed that GAL-101 was well-tolerated and has a strong safety and pharmacokinetic profile. These promising results have allowed […] The post Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases appeared first on Ph
STAT
MAY 1, 2025
The era of “tranq” may be ending. But tranq, as the powerful veterinary tranquilizer xylazine is known in the illicit drug supply, is being replaced at least in part by a dangerous new sedative: medetomidine. In the past year, the anesthetic has become an increasingly common element in the drug supply, with cities and states including Philadelphia, Pittsburgh, Chicago, and San Francisco reporting cases of medetomidine-involved overdoses.
Pharmacy Times
MAY 9, 2025
Student pharmacists can work toward a better future for patients, themselves, and the profession.
pharmaphorum
MAY 6, 2025
A potentially pivotal trial PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data
Drug Topics
MAY 9, 2025
Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst, discusses pharmacists ability to reach communities and address social determinants of health.
The Checkup by Singlecare
MAY 12, 2025
MiraLax is a popular brand-name, over-the-counter (OTC) laxative that helps relieve constipation. Containing the active ingredient polyethylene glycol 3350 (PEG 3350), MiraLax is FDA approved to treat occasional constipation in adults. It has several off-label uses, too, including treating chronic constipation, constipation related to irritable bowel syndrome (IBS), bowel preparation for colonoscopy procedures, and treating constipation in children (which the American Academy of Pediatrics consi
Fierce Healthcare
MAY 6, 2025
NEW ORLEANSIn the face of economic uncertainty, health system executives and venture capitalists are setting a high bar for digital health and artificial intelligence investments.
STAT
MAY 5, 2025
WASHINGTON — Hospitals, health centers, and patient advocates this week plan to escalate their pressure on federal lawmakers to oppose cuts to the Medicaid program. The groups are increasing their public calls to lawmakers, standing up new collaborations, and increasing investments in advertising to discourage lawmakers from cutting hundreds of billions of dollars in the program.
Let's personalize your content